Tania Perrone

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

Sandro Barni, Roberto Labianca, Giancarlo Agnelli et al. · Journal of Translational Medicine · 2011 · 100 citations · Full text

Medicine, Oncology, Pharmacology +17

Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists

Nicoletta Biglia, Valentina Elisabetta Bounous, Marta D’Alonzo et al. · Clinical Breast Cancer · 2017 · 90 citations · Full text

Medicine, Gynecology, Oncology +9

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

Michele Del Vecchio, Roberta Mortarini, Stefania Canova et al. · Clinical Cancer Research · 2010 · 58 citations

Pharmacy, Oncology, Pharmacology +17

Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy

Maurizio Musso, Renato Scalone, Vincenza Bonanno et al. · Supportive Care in Cancer · 2008 · 47 citations

Medicine, Pharmacology, Pharmacotherapy +12

Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study

Maurizio Musso, Renato Scalone, Gianpaolo Marcacci et al. · Bone Marrow Transplantation · 2009 · 43 citations · Full text

Medicine, Oncology, Pharmacology +11